Pharmacy

May 5 2018

Endo, feeling the pricing squeeze, could be the next generics player on the hunt for M – A: analyst, FiercePharma, endo pharma.#Endo #pharma

Endo, feeling the pricing squeeze, could be the next generics player on the hunt for M A: analyst Late last month, reports said Impax Labs may be looking to bulk up in the face of industry-wide generics pricing pressure with a deal for Amneal. And at least one analyst thinks it may make sense for Endo to follow suit. The way RBC Capital Markets’ Randall Stanicky sees it, Impax’ “game plan” could be “the answer” for the struggling Endo, which earlier this year recorded a $3.5 billion write-down that it largely attributed to the generics squeeze. And while that idea …

Mar 21 2018

FDA to drugmaker: Yank opioid Opana ER from market – CBS News, endo pharmaceuticals.#Endo #pharmaceuticals

CBS News Logo FDA to drugmaker: Yank opioid Opana ER from market TRENTON, N.J. — U.S. regulators want a narcotic painkiller involved in the opioid epidemic off the market amid data showing people continue to abuse it. Opana ER is shown in a file photo from 2013. The Food and Drug Administration said Thursday it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER, after concluding the drugs’s risks outweigh its benefits. It’s the first time the FDA has asked a drugmaker to remove an opioid painkiller from the market. The agency said it has seen …

Feb 13 2018

FDA to drugmaker: Yank opioid Opana ER from market – CBS News, endo pharmaceuticals careers.#Endo #pharmaceuticals #careers

CBS News Logo FDA to drugmaker: Yank opioid Opana ER from market TRENTON, N.J. — U.S. regulators want a narcotic painkiller involved in the opioid epidemic off the market amid data showing people continue to abuse it. Opana ER is shown in a file photo from 2013. The Food and Drug Administration said Thursday it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER, after concluding the drugs’s risks outweigh its benefits. It’s the first time the FDA has asked a drugmaker to remove an opioid painkiller from the market. The agency said it has seen …

Feb 3 2018

FDA to drugmaker: Yank opioid Opana ER from market – CBS News, endo pharmaceuticals.#Endo #pharmaceuticals

FDA to drugmaker: Yank opioid Opana ER from market TRENTON, N.J. — U.S. regulators want a narcotic painkiller involved in the opioid epidemic off the market amid data showing people continue to abuse it. The Food and Drug Administration said Thursday it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER, after concluding the drugs’s risks outweigh its benefits. It’s the first time the FDA has asked a drugmaker to remove an opioid painkiller from the market. The agency said it has seen a “significant shift” from people crushing and snorting Opana ER to get high …

Jan 12 2018

Endo, feeling the pricing squeeze, could be the next generics player on the hunt for M – A: analyst, FiercePharma, endo pharma.#Endo #pharma

Endo, feeling the pricing squeeze, could be the next generics player on the hunt for M A: analyst Late last month, reports said Impax Labs may be looking to bulk up in the face of industry-wide generics pricing pressure with a deal for Amneal. And at least one analyst thinks it may make sense for Endo to follow suit. The way RBC Capital Markets’ Randall Stanicky sees it, Impax’ “game plan” could be “the answer” for the struggling Endo, which earlier this year recorded a $3.5 billion write-down that it largely attributed to the generics squeeze. And while that idea …

Jan 7 2018

Endo Pharma’s stock logs its largest one-day loss in 14 years #pharma #companies #in #usa

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Dec 24 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #list #of #pharmaceutical #companies

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Dec 7 2017

Working at Endo Pharmaceuticals: 59 Reviews #ranbaxy #pharma

#endo pharma # Endo Pharmaceuticals Employee Reviews in United States Medical Science Operations Specialist (Former Employee) Malvern, PA January 28, 2016 Great place to work, gained a lot of valuable knowledge about the Pharma industry. Work was never boring, had a lot of versatility and challenging aspects to job function. Management was very helpful and supportive to my ideas, and helping me advance in my position(s). Co-workers were great, we worked together as a team on all projects. The most enjoyable part of the job was customer satisfaction. Ability to telecommute in bad weather. Sales associate (Former Employee) Las Vegas, …

Nov 29 2017

FTC Sues Endo Pharmaceuticals Inc #chinese #pharmaceutical #companies

#endo pharma # FTC Sues Endo Pharmaceuticals Inc. and Others for Illegally Blocking Lower-Cost Generic Versions of the Branded Drugs Opana ER and Lidoderm The Federal Trade Commission filed a complaint in federal district court alleging that Endo Pharmaceuticals Inc. and several other drug companies violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost generic versions of Opana ER and Lidoderm. Following more than a decade of FTC challenges to pay-for-delay settlements, today’s enforcement action is the first FTC case challenging an agreement not to market an authorized generic – often called a “no-AG commitment” – …

Nov 26 2017

Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al #dalton #pharma #services

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …

Nov 13 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #global #pharmaceutical #companies

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Nov 13 2017

From Valeant to Horizon and Endo, Pharma Gloom Spreads – The Big Number – MoneyBeat #pharmaceutical #formulation #companies

#endo pharma # From Valeant to Horizon and Endo, Pharma Gloom Spreads The Big Number Mar 21, 2016 8:55 am ET At the start of each week, MoneyBeat publishes a short column in the WSJ print edition highlighting a statistic getting traction in the markets. This week’s “big number“ is $19.67 billion, the combined decline in stock-market value of Valeant Pharmaceuticals International. Mallinckrodt PLC, Horizon Pharma PLC and Endo International PLC last week. Concerns about the fate of Valeant Pharmaceuticals International Inc. has investors not only fleeing Valeant s stock but also shares of companies that bear a resemblance to …

Sep 30 2017

Endo Pharmaceuticals down 40% #nectar #pharma

#endo pharma # A major drugmaker is crashing nearly 40% because it’s having to slash its prices A pill bottle installation on display at the alice + olivia by Stacey Bendet Fall 2016 presentation at The Gallery, Skylight at Clarkson Sq on February 16, 2016 in New York City. Rob Kim/Getty Images For alice + olivia by Stacey Bendet Endo Internationals’ stock is tanking after the company cautioned investors about a tough year ahead. The generics drugmaker of such pharmaceuticals as Percocet painkillers, is facing a drop in pricing power and scrutiny over its business model, sending the stock sliding. …

Sep 30 2017

Working at Endo Pharmaceuticals: 59 Reviews #jobs #in #pharmacy

#endo pharma # Endo Pharmaceuticals Employee Reviews in United States Medical Science Operations Specialist (Former Employee) Malvern, PA January 28, 2016 Great place to work, gained a lot of valuable knowledge about the Pharma industry. Work was never boring, had a lot of versatility and challenging aspects to job function. Management was very helpful and supportive to my ideas, and helping me advance in my position(s). Co-workers were great, we worked together as a team on all projects. The most enjoyable part of the job was customer satisfaction. Ability to telecommute in bad weather. Sales associate (Former Employee) Las Vegas, …

Sep 30 2017

From Valeant to Horizon and Endo, Pharma Gloom Spreads – The Big Number – MoneyBeat #pharma #international

#endo pharma # From Valeant to Horizon and Endo, Pharma Gloom Spreads The Big Number Mar 21, 2016 8:55 am ET At the start of each week, MoneyBeat publishes a short column in the WSJ print edition highlighting a statistic getting traction in the markets. This week’s “big number“ is $19.67 billion, the combined decline in stock-market value of Valeant Pharmaceuticals International. Mallinckrodt PLC, Horizon Pharma PLC and Endo International PLC last week. Concerns about the fate of Valeant Pharmaceuticals International Inc. has investors not only fleeing Valeant s stock but also shares of companies that bear a resemblance to …

Sep 9 2017

Endo to slash 740 jobs at AL, NC sites #generic #drug #industry

#pharmaceutical companies in charlotte nc # Endo to slash 740 jobs at AL, NC sites Suffering from several “previously unanticipated headwinds,” Endo is embarking on a plan to speed up restructuring efforts that will hit two of its manufacturing plants hard. The new strategy, which executives said they’re starting “shortly,” will impact 740 jobs. Endo plans to close a site in Charlotte, NC, and reduce its employee base in Huntsville, AL, as it battles pressure from “new competitive entrants; … greater than expected price erosion across the generics sector; and delays on regulatory actions related to certain Endo products,” CEO …

Sep 9 2017

Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al #pharmaceuticals #manufacturing

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …

Sep 5 2017

Working at Endo Pharmaceuticals: 59 Reviews #industry #pharmacy

#endo pharma # Endo Pharmaceuticals Employee Reviews in United States Medical Science Operations Specialist (Former Employee) Malvern, PA January 28, 2016 Great place to work, gained a lot of valuable knowledge about the Pharma industry. Work was never boring, had a lot of versatility and challenging aspects to job function. Management was very helpful and supportive to my ideas, and helping me advance in my position(s). Co-workers were great, we worked together as a team on all projects. The most enjoyable part of the job was customer satisfaction. Ability to telecommute in bad weather. Sales associate (Former Employee) Las Vegas, …

Sep 5 2017

FTC Sues Endo Pharmaceuticals Inc #the #drug #company

#endo pharma # FTC Sues Endo Pharmaceuticals Inc. and Others for Illegally Blocking Lower-Cost Generic Versions of the Branded Drugs Opana ER and Lidoderm The Federal Trade Commission filed a complaint in federal district court alleging that Endo Pharmaceuticals Inc. and several other drug companies violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost generic versions of Opana ER and Lidoderm. Following more than a decade of FTC challenges to pay-for-delay settlements, today’s enforcement action is the first FTC case challenging an agreement not to market an authorized generic – often called a “no-AG commitment” – …

Sep 5 2017

Endo International – American Medical Systems: Mesh Products #nutri #pharma

#endo pharma # Endo International and American Medical Systems Endo International PLC is a global health care company whose roots stretch back nearly a century. One of its companies, American Medical Systems, paid nearly $1 billion to settle vaginal mesh lawsuits. Thousands of cases remain. Its global headquarters is in Dublin, Ireland, with U.S. headquarters in Malvern, Penn. The company employs several thousand employees worldwide. Endo develops manufactures, markets and distributes pharmaceutical products and medical devices through its four operating companies: American Medical Systems (AMS): Pelvic health and continence-related devices Endo Pharmaceuticals: Branded pharmaceuticals Paladin Labs: Pharmaceutical products for Canadian …

Aug 31 2017

Endo to slash 740 jobs at AL, NC sites #pharmaceutical #manufacturing #industry

#pharmaceutical companies in charlotte nc # Endo to slash 740 jobs at AL, NC sites Suffering from several “previously unanticipated headwinds,” Endo is embarking on a plan to speed up restructuring efforts that will hit two of its manufacturing plants hard. The new strategy, which executives said they’re starting “shortly,” will impact 740 jobs. Endo plans to close a site in Charlotte, NC, and reduce its employee base in Huntsville, AL, as it battles pressure from “new competitive entrants; … greater than expected price erosion across the generics sector; and delays on regulatory actions related to certain Endo products,” CEO …

Aug 25 2017

FTC Sues Endo Pharmaceuticals Inc #pharma #pricing

#endo pharma # FTC Sues Endo Pharmaceuticals Inc. and Others for Illegally Blocking Lower-Cost Generic Versions of the Branded Drugs Opana ER and Lidoderm The Federal Trade Commission filed a complaint in federal district court alleging that Endo Pharmaceuticals Inc. and several other drug companies violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost generic versions of Opana ER and Lidoderm. Following more than a decade of FTC challenges to pay-for-delay settlements, today’s enforcement action is the first FTC case challenging an agreement not to market an authorized generic – often called a “no-AG commitment” – …

Aug 24 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #sk #pharma

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Aug 24 2017

Working at Endo Pharmaceuticals: 59 Reviews #pharma.com

#endo pharma # Endo Pharmaceuticals Employee Reviews in United States Medical Science Operations Specialist (Former Employee) Malvern, PA January 28, 2016 Great place to work, gained a lot of valuable knowledge about the Pharma industry. Work was never boring, had a lot of versatility and challenging aspects to job function. Management was very helpful and supportive to my ideas, and helping me advance in my position(s). Co-workers were great, we worked together as a team on all projects. The most enjoyable part of the job was customer satisfaction. Ability to telecommute in bad weather. Sales associate (Former Employee) Las Vegas, …

Aug 14 2017

Working at Endo Pharmaceuticals: 59 Reviews #pharma #conference

#endo pharma # Endo Pharmaceuticals Employee Reviews in United States Medical Science Operations Specialist (Former Employee) Malvern, PA January 28, 2016 Great place to work, gained a lot of valuable knowledge about the Pharma industry. Work was never boring, had a lot of versatility and challenging aspects to job function. Management was very helpful and supportive to my ideas, and helping me advance in my position(s). Co-workers were great, we worked together as a team on all projects. The most enjoyable part of the job was customer satisfaction. Ability to telecommute in bad weather. Sales associate (Former Employee) Las Vegas, …

Aug 11 2017

Endo to slash 740 jobs at AL, NC sites #ono #pharma

#pharmaceutical companies in charlotte nc # Endo to slash 740 jobs at AL, NC sites Suffering from several “previously unanticipated headwinds,” Endo is embarking on a plan to speed up restructuring efforts that will hit two of its manufacturing plants hard. The new strategy, which executives said they’re starting “shortly,” will impact 740 jobs. Endo plans to close a site in Charlotte, NC, and reduce its employee base in Huntsville, AL, as it battles pressure from “new competitive entrants; … greater than expected price erosion across the generics sector; and delays on regulatory actions related to certain Endo products,” CEO …

Aug 7 2017

Working at Endo Pharmaceuticals: 59 Reviews #chugai #pharma

#endo pharma # Endo Pharmaceuticals Employee Reviews in United States Medical Science Operations Specialist (Former Employee) Malvern, PA January 28, 2016 Great place to work, gained a lot of valuable knowledge about the Pharma industry. Work was never boring, had a lot of versatility and challenging aspects to job function. Management was very helpful and supportive to my ideas, and helping me advance in my position(s). Co-workers were great, we worked together as a team on all projects. The most enjoyable part of the job was customer satisfaction. Ability to telecommute in bad weather. Sales associate (Former Employee) Las Vegas, …

Aug 7 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #pharma #it #jobs

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Jul 31 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #pharmaceutical #industry #today

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Jul 31 2017

FTC Sues Endo Pharmaceuticals Inc #pharmaceutical #industry #research

#endo pharma # FTC Sues Endo Pharmaceuticals Inc. and Others for Illegally Blocking Lower-Cost Generic Versions of the Branded Drugs Opana ER and Lidoderm The Federal Trade Commission filed a complaint in federal district court alleging that Endo Pharmaceuticals Inc. and several other drug companies violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost generic versions of Opana ER and Lidoderm. Following more than a decade of FTC challenges to pay-for-delay settlements, today’s enforcement action is the first FTC case challenging an agreement not to market an authorized generic – often called a “no-AG commitment” – …

Jul 31 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #pharmaceutical #manufacturing #magazine

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Jul 26 2017

Endo to slash 740 jobs at AL, NC sites #pharmaceutical #company #names

#pharmaceutical companies in charlotte nc # Endo to slash 740 jobs at AL, NC sites Suffering from several “previously unanticipated headwinds,” Endo is embarking on a plan to speed up restructuring efforts that will hit two of its manufacturing plants hard. The new strategy, which executives said they’re starting “shortly,” will impact 740 jobs. Endo plans to close a site in Charlotte, NC, and reduce its employee base in Huntsville, AL, as it battles pressure from “new competitive entrants; … greater than expected price erosion across the generics sector; and delays on regulatory actions related to certain Endo products,” CEO …

Jul 22 2017

Working at Endo Pharmaceuticals: 59 Reviews #pharmaceutical #companies #in #houston #tx

#endo pharma # Endo Pharmaceuticals Employee Reviews in United States Medical Science Operations Specialist (Former Employee) Malvern, PA January 28, 2016 Great place to work, gained a lot of valuable knowledge about the Pharma industry. Work was never boring, had a lot of versatility and challenging aspects to job function. Management was very helpful and supportive to my ideas, and helping me advance in my position(s). Co-workers were great, we worked together as a team on all projects. The most enjoyable part of the job was customer satisfaction. Ability to telecommute in bad weather. Sales associate (Former Employee) Las Vegas, …

Jul 22 2017

From Valeant to Horizon and Endo, Pharma Gloom Spreads – The Big Number – MoneyBeat #pharma #technology

#endo pharma # From Valeant to Horizon and Endo, Pharma Gloom Spreads The Big Number Mar 21, 2016 8:55 am ET At the start of each week, MoneyBeat publishes a short column in the WSJ print edition highlighting a statistic getting traction in the markets. This week’s “big number“ is $19.67 billion, the combined decline in stock-market value of Valeant Pharmaceuticals International. Mallinckrodt PLC, Horizon Pharma PLC and Endo International PLC last week. Concerns about the fate of Valeant Pharmaceuticals International Inc. has investors not only fleeing Valeant s stock but also shares of companies that bear a resemblance to …

Jul 8 2017

From Valeant to Horizon and Endo, Pharma Gloom Spreads – The Big Number – MoneyBeat #pharma #careers

#endo pharma # From Valeant to Horizon and Endo, Pharma Gloom Spreads The Big Number Mar 21, 2016 8:55 am ET At the start of each week, MoneyBeat publishes a short column in the WSJ print edition highlighting a statistic getting traction in the markets. This week’s “big number“ is $19.67 billion, the combined decline in stock-market value of Valeant Pharmaceuticals International. Mallinckrodt PLC, Horizon Pharma PLC and Endo International PLC last week. Concerns about the fate of Valeant Pharmaceuticals International Inc. has investors not only fleeing Valeant s stock but also shares of companies that bear a resemblance to …

Jul 8 2017

Endo Pharmaceuticals down 40% #uk #pharmaceutical #companies

#endo pharma # A major drugmaker is crashing nearly 40% because it’s having to slash its prices A pill bottle installation on display at the alice + olivia by Stacey Bendet Fall 2016 presentation at The Gallery, Skylight at Clarkson Sq on February 16, 2016 in New York City. Rob Kim/Getty Images For alice + olivia by Stacey Bendet Endo Internationals’ stock is tanking after the company cautioned investors about a tough year ahead. The generics drugmaker of such pharmaceuticals as Percocet painkillers, is facing a drop in pricing power and scrutiny over its business model, sending the stock sliding. …

Jun 25 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #esai #pharma

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Jun 25 2017

Endo International – American Medical Systems: Mesh Products #pharma #trust

#endo pharma # Endo International and American Medical Systems Endo International PLC is a global health care company whose roots stretch back nearly a century. One of its companies, American Medical Systems, paid nearly $1 billion to settle vaginal mesh lawsuits. Thousands of cases remain. Its global headquarters is in Dublin, Ireland, with U.S. headquarters in Malvern, Penn. The company employs several thousand employees worldwide. Endo develops manufactures, markets and distributes pharmaceutical products and medical devices through its four operating companies: American Medical Systems (AMS): Pelvic health and continence-related devices Endo Pharmaceuticals: Branded pharmaceuticals Paladin Labs: Pharmaceutical products for Canadian …

Jun 12 2017

Working at Endo Pharmaceuticals: 59 Reviews #pharma #sales #recruiters

#endo pharma # Endo Pharmaceuticals Employee Reviews in United States Medical Science Operations Specialist (Former Employee) Malvern, PA January 28, 2016 Great place to work, gained a lot of valuable knowledge about the Pharma industry. Work was never boring, had a lot of versatility and challenging aspects to job function. Management was very helpful and supportive to my ideas, and helping me advance in my position(s). Co-workers were great, we worked together as a team on all projects. The most enjoyable part of the job was customer satisfaction. Ability to telecommute in bad weather. Sales associate (Former Employee) Las Vegas, …

Jun 12 2017

Endo Pharmaceuticals down 40% #sami #pharma

#endo pharma # A major drugmaker is crashing nearly 40% because it’s having to slash its prices A pill bottle installation on display at the alice + olivia by Stacey Bendet Fall 2016 presentation at The Gallery, Skylight at Clarkson Sq on February 16, 2016 in New York City. Rob Kim/Getty Images For alice + olivia by Stacey Bendet Endo Internationals’ stock is tanking after the company cautioned investors about a tough year ahead. The generics drugmaker of such pharmaceuticals as Percocet painkillers, is facing a drop in pricing power and scrutiny over its business model, sending the stock sliding. …

May 28 2017

Endo Pharmaceuticals down 40% #bsp #pharma #inc

#endo pharma # A major drugmaker is crashing nearly 40% because it’s having to slash its prices A pill bottle installation on display at the alice + olivia by Stacey Bendet Fall 2016 presentation at The Gallery, Skylight at Clarkson Sq on February 16, 2016 in New York City. Rob Kim/Getty Images For alice + olivia by Stacey Bendet Endo Internationals’ stock is tanking after the company cautioned investors about a tough year ahead. The generics drugmaker of such pharmaceuticals as Percocet painkillers, is facing a drop in pricing power and scrutiny over its business model, sending the stock sliding. …

May 18 2017

Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al #pharma #packaging

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …

May 13 2017

Endo Pharmaceuticals down 40% #eli #lilly #pharma

#endo pharma # A major drugmaker is crashing nearly 40% because it’s having to slash its prices A pill bottle installation on display at the alice + olivia by Stacey Bendet Fall 2016 presentation at The Gallery, Skylight at Clarkson Sq on February 16, 2016 in New York City. Rob Kim/Getty Images For alice + olivia by Stacey Bendet Endo Internationals’ stock is tanking after the company cautioned investors about a tough year ahead. The generics drugmaker of such pharmaceuticals as Percocet painkillers, is facing a drop in pricing power and scrutiny over its business model, sending the stock sliding. …

May 13 2017

Working at Endo Pharmaceuticals: 59 Reviews #spi #pharma

#endo pharma # Endo Pharmaceuticals Employee Reviews in United States Medical Science Operations Specialist (Former Employee) Malvern, PA January 28, 2016 Great place to work, gained a lot of valuable knowledge about the Pharma industry. Work was never boring, had a lot of versatility and challenging aspects to job function. Management was very helpful and supportive to my ideas, and helping me advance in my position(s). Co-workers were great, we worked together as a team on all projects. The most enjoyable part of the job was customer satisfaction. Ability to telecommute in bad weather. Sales associate (Former Employee) Las Vegas, …

May 13 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #jamjoom #pharma

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

May 13 2017

From Valeant to Horizon and Endo, Pharma Gloom Spreads – The Big Number – MoneyBeat #ajanta #pharma #kamagra

#endo pharma # From Valeant to Horizon and Endo, Pharma Gloom Spreads The Big Number Mar 21, 2016 8:55 am ET At the start of each week, MoneyBeat publishes a short column in the WSJ print edition highlighting a statistic getting traction in the markets. This week’s “big number“ is $19.67 billion, the combined decline in stock-market value of Valeant Pharmaceuticals International. Mallinckrodt PLC, Horizon Pharma PLC and Endo International PLC last week. Concerns about the fate of Valeant Pharmaceuticals International Inc. has investors not only fleeing Valeant s stock but also shares of companies that bear a resemblance to …

May 2 2017

Endo to slash 740 jobs at AL, NC sites #pharmaceutical #contract #manufacturing #companies

#pharmaceutical companies in charlotte nc # Endo to slash 740 jobs at AL, NC sites Suffering from several “previously unanticipated headwinds,” Endo is embarking on a plan to speed up restructuring efforts that will hit two of its manufacturing plants hard. The new strategy, which executives said they’re starting “shortly,” will impact 740 jobs. Endo plans to close a site in Charlotte, NC, and reduce its employee base in Huntsville, AL, as it battles pressure from “new competitive entrants; … greater than expected price erosion across the generics sector; and delays on regulatory actions related to certain Endo products,” CEO …

Apr 26 2017

From Valeant to Horizon and Endo, Pharma Gloom Spreads – The Big Number – MoneyBeat #lilly #pharma

#endo pharma # From Valeant to Horizon and Endo, Pharma Gloom Spreads The Big Number Mar 21, 2016 8:55 am ET At the start of each week, MoneyBeat publishes a short column in the WSJ print edition highlighting a statistic getting traction in the markets. This week’s “big number“ is $19.67 billion, the combined decline in stock-market value of Valeant Pharmaceuticals International. Mallinckrodt PLC, Horizon Pharma PLC and Endo International PLC last week. Concerns about the fate of Valeant Pharmaceuticals International Inc. has investors not only fleeing Valeant s stock but also shares of companies that bear a resemblance to …

Apr 26 2017

Endo Pharma’s stock logs its largest one-day loss in 14 years #pharma #pricing

#endo pharma # Endo Pharma’s stock logs its largest one-day loss in 14 years Shares of Endo Pharmaceuticals plunged in heavy trade Friday, as they suffered their worst one-day decline in 14 years on the heels of a disappointing outlook for profit and sales. The Dublin, Ireland-based drugmaker’s stock ENDP, -2.03% tumbled 39% to the lowest close at the lowest level since May 29, 2009. That’s the third-biggest percentage selloff since the company went public in September 1996, behind the 46% drop on June, 24, 2002 and the 59% crash on Aug. 3, 1999. The rout shaved about $2.3 billion …

Apr 23 2017

Endo to slash 740 jobs at AL, NC sites #pliva #pharma

#pharmaceutical companies in charlotte nc # Endo to slash 740 jobs at AL, NC sites Suffering from several “previously unanticipated headwinds,” Endo is embarking on a plan to speed up restructuring efforts that will hit two of its manufacturing plants hard. The new strategy, which executives said they’re starting “shortly,” will impact 740 jobs. Endo plans to close a site in Charlotte, NC, and reduce its employee base in Huntsville, AL, as it battles pressure from “new competitive entrants; … greater than expected price erosion across the generics sector; and delays on regulatory actions related to certain Endo products,” CEO …